JBS is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows potential upside based on analyst ratings, technical indicators, and a favorable options sentiment. Despite weaker recent financial performance, the company's growth initiatives and expected re-rating post-U.S. listing make it a solid long-term investment.
The stock's moving averages (SMA_5 > SMA_20 > SMA_200) indicate a bullish trend. However, the MACD is negatively expanding (-0.0927), and RSI is neutral at 30.244. Key support is at 15.702, with resistance at 16.84. The stock is trading close to its support level, which could provide a good entry point.

UBS initiated coverage with a Buy rating and a $19.50 price target, implying 23% upside.
Expected re-rating post-U.S. listing and index inclusion.
$1B annual expansion capex remains unpriced by the market.
Recent financial performance shows declining net income (-16.17% YoY) and EPS (-16.13% YoY).
Gross margin dropped significantly (-20.11% YoY).
In Q3 2025, revenue increased by 13.40% YoY to $22.6B, but net income dropped by 16.17% YoY to $580.9M. EPS also declined by 16.13% YoY to $0.52, and gross margin fell by 20.11% to 13.15%.
UBS initiated coverage with a Buy rating and a $19.50 price target, implying 23% upside. Grupo Santander recently upgraded the stock to Outperform with a $17 price target.